Race Oncology opened patient enrolment at a second site for its Phase 1 clinical trial of RC220 in patients with advanced solid tumours, the company announced on Tuesday. The Central Coast Local Health District, comprising Gosford and Wyong Hospitals, has been activated following the earlier activation of the lead Australian site, Southside Cancer Centre in…
A new startup aimed at discovering and developing anti-inflammatory disease medicines has been formed by The University of Queensland’s commercialisation arm UniQuest and global biotech company Molecule to Medicine (MTM), according to a statement released on Tuesday. Curlew Bio will leverage expertise from the Queensland Emory and Drug Discovery Initiative (QEDDI) and research developed by…
Avecho Biotechnology signed an exclusive ten-year development and licensing agreement with Sandoz for the commercial rights to its cannabidiol (CBD) insomnia treatment in Australia, according to an ASX announcement released on Monday. The deal includes an upfront payment of US$3 million (approximately A$4.8 million) and potential development milestone payments totalling US$16 million prior to commercialisation.…
Moderna has opened the Southern Hemisphere’s only mRNA vaccine manufacturing site in Victoria, aiming to make 100 million doses a year.
Animal health company Zoetis has bought a 21-acre manufacturing site in Melbourne to significantly expand its operations and increase capabilities to manufacture vaccines for sheep, cattle, dogs, cats and horses. The company which produces 130 million doses of vaccines for companion animals and livestock in Australia each year, said the expansion would support development of…
